These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8588244)

  • 1. Elucidating the mechanism of action of the immunosuppressant 15-deoxyspergualin.
    Nadler SG; Eversole AC; Tepper MA; Cleaveland JS
    Ther Drug Monit; 1995 Dec; 17(6):700-3. PubMed ID: 8588244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of the interaction of the immunosuppressant deoxyspergualin and analogs with Hsc70 and Hsp90.
    Nadeau K; Nadler SG; Saulnier M; Tepper MA; Walsh CT
    Biochemistry; 1994 Mar; 33(9):2561-7. PubMed ID: 8117717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyspergualin inhibits kappa light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-kappa B activation.
    Tepper MA; Nadler SG; Esselstyn JM; Sterbenz KG
    J Immunol; 1995 Sep; 155(5):2427-36. PubMed ID: 7650374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a binding site on Hsc70 for the immunosuppressant 15-deoxyspergualin.
    Nadler SG; Dischino DD; Malacko AR; Cleaveland JS; Fujihara SM; Marquardt H
    Biochem Biophys Res Commun; 1998 Dec; 253(1):176-80. PubMed ID: 9875240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins.
    Nadler SG; Tepper MA; Schacter B; Mazzucco CE
    Science; 1992 Oct; 258(5081):484-6. PubMed ID: 1411548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of the molecular chaperone-specific immunosuppressive agent 15-deoxyspergualin: modulation of Hsc70 ATPase activity without compromising DnaJ chaperone interactions.
    Brodsky JL
    Biochem Pharmacol; 1999 Apr; 57(8):877-80. PubMed ID: 10086320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity capillary electrophoresis applied to the studies of interactions of a member of heat shock protein family with an immunosuppressant.
    Liu J; Volk KJ; Lee MS; Kerns EH; Rosenberg IE
    J Chromatogr A; 1994 Oct; 680(2):395-403. PubMed ID: 7981823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamine compound deoxyspergualin inhibits heat shock protein-induced activation of immature dendritic cells.
    Sugawara A; Torigoe T; Tamura Y; Kamiguchi K; Nemoto K; Oguro H; Sato N
    Cell Stress Chaperones; 2009 Mar; 14(2):133-9. PubMed ID: 18686015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of poly(rC) binding protein 2 (PCBP2) as a target protein of immunosuppressive agent 15-deoxyspergualin.
    Murahashi M; Simizu S; Morioka M; Umezawa K
    Biochem Biophys Res Commun; 2016 Aug; 476(4):445-449. PubMed ID: 27261432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Deoxyspergualin modulates Plasmodium falciparum heat shock protein function.
    Ramya TN; Surolia N; Surolia A
    Biochem Biophys Res Commun; 2006 Sep; 348(2):585-92. PubMed ID: 16884692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes.
    Hoeger PH; Tepper MA; Faith A; Higgins JA; Lamb JR; Geha RS
    J Immunol; 1994 Nov; 153(9):3908-16. PubMed ID: 7930603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-deoxyspergualin inhibits eukaryotic protein synthesis through eIF2alpha phosphorylation.
    Ramya TN; Surolia N; Surolia A
    Biochem J; 2007 Jan; 401(2):411-20. PubMed ID: 16952278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxyspergualin--a novel immunosuppressant.
    Jindal RM; Tepper MA; Soltys K; Cho SI
    Mt Sinai J Med; 1994 Jan; 61(1):51-6. PubMed ID: 8183294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A member of the Hsp70 family of heat-shock proteins is a putative target for the immunosuppressant 15-deoxyspergualin.
    Mazzucco CE; Nadler SG
    Ann N Y Acad Sci; 1993 Jun; 685():202-4. PubMed ID: 8363224
    [No Abstract]   [Full Text] [Related]  

  • 15. 15-Deoxyspergualin: a newly developed immunosuppressive agent and its mechanism of action and clinical effect: a review. Japan Collaborative Transplant Study Group for NKT-01.
    Amemiya H
    Artif Organs; 1996 Aug; 20(8):832-5. PubMed ID: 8853792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced levels of Hsp70 result in a therapeutic effect of 15-deoxyspergualin on acute graft-versus-host disease in (DA x LEW)F1 rats.
    Goral J; Mathews HL; Nadler SG; Clancy J
    Immunobiology; 2000 Sep; 202(3):254-66. PubMed ID: 11045661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the interaction of the immunosuppressant 15-deoxyspergualin with heat shock proteins.
    Nadler SG; Cleaveland J; Tepper MA; Walsh C; Nadeau K
    Ann N Y Acad Sci; 1993 Nov; 696():412-4. PubMed ID: 8109853
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of in vivo immunosuppressive and in vitro interaction with constitutive heat shock protein 70 activity of LF08-0299 (Tresperimus) and analogues.
    Komesli S; Dumas C; Dutartre P
    Int J Immunopharmacol; 1999 May; 21(5):349-58. PubMed ID: 10408631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyspergualin: mechanism of action and pharmacokinetics.
    Ramos EL; Nadler SG; Grasela DM; Kelley SL
    Transplant Proc; 1996 Apr; 28(2):873-5. PubMed ID: 8623442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.